600812 华北制药
已收盘 02-04 15:00:00
资讯
新帖
简况
华北制药（600812）披露为下属子公司提供担保公告，2月2日股价下跌2.29%
证券之星 · 02-02 22:29
华北制药（600812）披露为下属子公司提供担保公告，2月2日股价下跌2.29%
华北制药（600812）披露获得他克莫司胶囊《药品注册证书》，1月26日股价上涨3.01%
证券之星 · 01-26
华北制药（600812）披露获得他克莫司胶囊《药品注册证书》，1月26日股价上涨3.01%
每周股票复盘：华北制药（600812）先泰药业冻干生产线通过GMP检查
证券之星 · 01-25
每周股票复盘：华北制药（600812）先泰药业冻干生产线通过GMP检查
华北制药：全资子公司通过药品GMP符合性检查
新京报 · 01-23
华北制药：全资子公司通过药品GMP符合性检查
每周股票复盘：华北制药（600812）为子公司提供合计5.18亿担保
证券之星 · 01-11
每周股票复盘：华北制药（600812）为子公司提供合计5.18亿担保
华北制药（600812）披露为下属子公司提供担保公告，1月5日股价上涨0.9%
证券之星 · 01-05
华北制药（600812）披露为下属子公司提供担保公告，1月5日股价上涨0.9%
每周股票复盘：华北制药（600812）推“提质增效重回报”方案
证券之星 · 01-02
每周股票复盘：华北制药（600812）推“提质增效重回报”方案
华北制药（600812）披露“提质增效重回报”行动方案，12月29日股价下跌1.07%
证券之星 · 2025-12-29
华北制药（600812）披露“提质增效重回报”行动方案，12月29日股价下跌1.07%
华北制药（600812）披露为下属子公司提供担保的公告，12月2日股价上涨0.17%
证券之星 · 2025-12-02
华北制药（600812）披露为下属子公司提供担保的公告，12月2日股价上涨0.17%
每周股票复盘：华北制药（600812）完成5亿短期融资券兑付
证券之星 · 2025-11-23
每周股票复盘：华北制药（600812）完成5亿短期融资券兑付
华北制药（600812）披露召开2025年第三季度业绩说明会公告，11月19日股价下跌1.81%
证券之星 · 2025-11-19
华北制药（600812）披露召开2025年第三季度业绩说明会公告，11月19日股价下跌1.81%
每周股票复盘：华北制药（600812）子公司获原料药上市批准
证券之星 · 2025-11-09
每周股票复盘：华北制药（600812）子公司获原料药上市批准
华北制药（600812）披露下属公司获得《化学原料药上市申请批准通知书》，11月04日股价下跌0.65%
证券之星 · 2025-11-04
华北制药（600812）披露下属公司获得《化学原料药上市申请批准通知书》，11月04日股价下跌0.65%
华北制药(600812.SH)：头孢托仑匹酯化学原料药上市申请获批准
智通财经 · 2025-11-04
华北制药(600812.SH)：头孢托仑匹酯化学原料药上市申请获批准
华北制药（600812）2025年三季报简析：净利润同比增长54.69%，短期债务压力上升
证券之星 · 2025-10-26
华北制药（600812）2025年三季报简析：净利润同比增长54.69%，短期债务压力上升
华北制药（600812）披露2025年第三季度报告，10月24日股价下跌0.33%
证券之星 · 2025-10-24
华北制药（600812）披露2025年第三季度报告，10月24日股价下跌0.33%
每周股票复盘：华北制药（600812）董事会延期换届
证券之星 · 2025-10-12
每周股票复盘：华北制药（600812）董事会延期换届
华北制药（600812）披露关于董事会延期换届的提示性公告，10月10日股价上涨1.18%
证券之星 · 2025-10-10
华北制药（600812）披露关于董事会延期换届的提示性公告，10月10日股价上涨1.18%
每周股票复盘：华北制药（600812）子公司获注射用亚胺培南西司他丁钠药品注册证
证券之星 · 2025-09-21
每周股票复盘：华北制药（600812）子公司获注射用亚胺培南西司他丁钠药品注册证
华北制药最新公告：全资子公司获得注射用亚胺培南西司他丁钠药品注册证书
证券之星 · 2025-09-16
华北制药最新公告：全资子公司获得注射用亚胺培南西司他丁钠药品注册证书
加载更多
公司概况
公司名称：
华北制药股份有限公司
所属行业：
医药制造业
上市日期：
1994-01-14
主营业务：
华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是抗感染药物、防疫类药物、肾病及免疫调节剂、心脑血管类药物、维生素及健康消费品。公司曾先后获得国家发明奖5项、科技进步奖21项；被授予“中国医药行业功勋企业”和“中国制药大王”“全国医药行业药品质量诚信建设示范企业”等称号。
发行价格：
4.00
{"stockData":{"symbol":"600812","market":"SH","secType":"STK","nameCN":"华北制药","latestPrice":5.61,"timestamp":1770188401000,"preClose":5.58,"halted":0,"volume":12986213,"delay":0,"changeRate":0.0054,"floatShares":1716000000,"shares":1716000000,"eps":0.1067,"marketStatus":"已收盘","change":0.03,"latestTime":"02-04 15:00:00","open":5.55,"high":5.61,"low":5.54,"amount":72353400,"amplitude":0.0125,"askPrice":5.61,"askSize":4707,"bidPrice":5.6,"bidSize":11738,"shortable":0,"etf":0,"ttmEps":0.1067,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":5,"adr":0,"adjPreClose":5.58,"symbolType":"stock","openAndCloseTimeList":[[1770168600000,1770175800000],[1770181200000,1770188400000]],"highLimit":6.14,"lowLimit":5.02,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1715730370,"isCdr":false,"pbRate":1.75,"roa":"--","peRate":52.57732,"roe":"2.898%","epsLYR":0.074,"committee":0.183707,"marketValue":9625000000,"turnoverRate":0.0076,"status":0,"floatMarketCap":9625000000},"requestUrl":"/m/hq/s/600812","defaultTab":"news","newsList":[{"id":"2608672418","title":"华北制药（600812）披露为下属子公司提供担保公告，2月2日股价下跌2.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608672418","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608672418?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:29","pubTimestamp":1770042559,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，华北制药报收于5.54元，较前一交易日下跌2.29%，最新总市值为95.05亿元。近日，华北制药股份有限公司发布《关于为下属子公司提供担保的公告》。公告显示，公司为全资子公司华北制药河北华民药业有限责任公司提供14,000万元连带责任保证担保，用于其流动资金借款。截至公告日，公司已实际为华民公司提供担保余额68,300万元。公司及控股子公司对外担保总额为164,403.06万元，占最近一期经审计净资产的30.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0191","600812"],"gpt_icon":0},{"id":"2606249651","title":"华北制药（600812）披露获得他克莫司胶囊《药品注册证书》，1月26日股价上涨3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606249651","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606249651?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:45","pubTimestamp":1769438716,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，华北制药报收于5.82元，较前一交易日上涨3.01%，最新总市值为99.86亿元。该股当日开盘5.66元，最高5.85元，最低5.65元，成交额达3.46亿元，换手率为3.5%。华北制药股份有限公司近日收到国家药品监督管理局核准签发的他克莫司胶囊《药品注册证书》，批准注册并视为通过仿制药质量和疗效一致性评价。截至目前，国内共有8家企业持有该规格他克莫司胶囊的注册证书。该产品的获批有助于完善公司在免疫抑制领域的产品结构。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600036626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0028","BK0191","BK0239"],"gpt_icon":0},{"id":"2606234145","title":"每周股票复盘：华北制药（600812）先泰药业冻干生产线通过GMP检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234145","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234145?lang=zh_cn&edition=full","pubTime":"2026-01-25 01:50","pubTimestamp":1769277017,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，华北制药报收于5.65元，较上周的5.58元上涨1.25%。本周，华北制药1月20日盘中最高价报5.68元。本周关注点来自公司公告汇总：全资子公司先泰药业802车间冻干生产线2号线通过无菌原料药哌拉西林钠GMP符合性检查。此次检查通过不影响公司当前经营业绩，但有助于满足市场需求，保障用药供应。华北制药股份有限公司目前指定的信息披露媒体为《中国证券报》《上海证券报》和上海证券交易所网站。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600812","BK0239","BK0028"],"gpt_icon":0},{"id":"2605678478","title":"华北制药：全资子公司通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2605678478","media":"新京报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605678478?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:49","pubTimestamp":1769158140,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 1月23日，华北制药公告，全资子公司华北制药集团先泰药业有限公司收到河北省药品监督管理局签发的《药品GMP符合性检查告知书》。检查范围为无菌原料药(哌拉西林钠，802车间冻干生产线2号线)，检查时间2025年12月9日至2025年12月12日，检查结论为符合《药品生产质量管理规范(2010年修订)》及其附录要求。802车间冻干生产线2号线年生产能力为150吨/年，主要产品为哌拉西林钠，累计投资7457.44万元。此次检查是哌拉西林钠新增冻干生产线2号线进行注册备案后首次药品GMP符合性检查。","market":"sh","thumbnail":"https://media.bjnews.com.cn/cover/2026/01/22/5678522835337817085.png?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/01/22/5678522835337817085.png?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1769157735129971.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1769157735129971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0239","600812","BK0028","BK0191"],"gpt_icon":0},{"id":"2602364075","title":"每周股票复盘：华北制药（600812）为子公司提供合计5.18亿担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2602364075","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602364075?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:09","pubTimestamp":1768075748,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，华北制药报收于5.67元，较上周的5.53元上涨2.53%。本周，华北制药1月9日盘中最高价报5.67元。华北制药当前最新总市值97.28亿元，在化学制药板块市值排名58/150，在两市A股市值排名2082/5182。本周关注点公司公告汇总：华北制药为下属子公司提供合计51,775万元连带责任保证担保。截至公告日，公司及控股子公司对外担保总额为180,218.06万元，占最近一期经审计净资产的33.44%。存在逾期担保金额9,000万元，为对合并报表外单位石家庄焦化集团的担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","600812","BK0028"],"gpt_icon":0},{"id":"2601801728","title":"华北制药（600812）披露为下属子公司提供担保公告，1月5日股价上涨0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801728","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801728?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:54","pubTimestamp":1767624853,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，华北制药报收于5.58元，较前一交易日上涨0.9%，最新总市值为95.74亿元。近日，华北制药股份有限公司发布公告称，公司为下属子公司华北制药河北华民药业有限责任公司、华北制药金坦生物技术股份有限公司、华北制药集团爱诺有限公司分别提供34,800万元、4,975万元、12,000万元连带责任保证担保。截至公告日，公司及控股子公司对外担保总额为180,218.06万元，占最近一期经审计净资产的33.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","BK0028","600812"],"gpt_icon":0},{"id":"2600934039","title":"每周股票复盘：华北制药（600812）推“提质增效重回报”方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2600934039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600934039?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:07","pubTimestamp":1767298031,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，华北制药报收于5.62元，较上周的5.65元下跌0.53%。本周，华北制药12月23日盘中最高价报5.79元。本周关注点公司公告汇总：华北制药发布“提质增效重回报”行动方案，涵盖主业聚焦、股东回报等多项举措。华北制药发布“提质增效重回报”行动方案，内容包括聚焦主责主业、提升经营质量、重视股东回报、坚持科技创新、强化投资者关系管理、规范运作及治理水平提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600812","BK0028","BK0239"],"gpt_icon":0},{"id":"2595736575","title":"华北制药（600812）披露“提质增效重回报”行动方案，12月29日股价下跌1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595736575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595736575?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:42","pubTimestamp":1767019335,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，华北制药报收于5.56元，较前一交易日下跌1.07%，最新总市值为95.39亿元。近日，华北制药发布“提质增效重回报”行动方案。公司制定2023-2025年股东回报规划，近三年累计现金分红6,862.92万元，不低于年均净利润的30%。同日，公司发布的第十一届董事会第二十六次会议决议公告显示，会议审议通过《关于制定“提质增效重回报”行动方案的议案》，表决结果为同意10票，反对0票，弃权0票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0028","BK0191","BK0239"],"gpt_icon":0},{"id":"2588059098","title":"华北制药（600812）披露为下属子公司提供担保的公告，12月2日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588059098?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:27","pubTimestamp":1764685662,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，华北制药报收于5.87元，较前一交易日上涨0.17%，最新总市值为100.71亿元。公司近日发布公告称，华北制药股份有限公司为全资子公司华北制药集团先泰药业有限公司提供3,000万元连带责任保证担保，用于其项目贷款。本次担保在公司2024年年度股东大会审议通过的担保额度内，无需另行审议。截至公告日，公司为先泰公司实际担保余额为12,500万元。公司及控股子公司对外担保总额为153,913.06万元，占最近一期经审计净资产的28.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","600812","BK0191"],"gpt_icon":0},{"id":"2585010378","title":"每周股票复盘：华北制药（600812）完成5亿短期融资券兑付","url":"https://stock-news.laohu8.com/highlight/detail?id=2585010378","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585010378?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:02","pubTimestamp":1763838137,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，华北制药报收于5.71元，较上周的6.23元下跌8.35%。本周，华北制药11月17日盘中最高价报6.27元。公司公告汇总华北制药股份有限公司于2025年5月16日发行2025年度第一期短期融资券，发行总额为人民币5.00亿元，发行利率1.86%，期限180日，兑付日期为2025年11月15日。截至2025年11月17日，公司已完成本期短期融资券的兑付工作，本息兑付金额共计人民币504,586,301.37元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","BK0028","600812"],"gpt_icon":0},{"id":"2584947888","title":"华北制药（600812）披露召开2025年第三季度业绩说明会公告，11月19日股价下跌1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947888","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947888?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:20","pubTimestamp":1763562044,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，华北制药报收于5.96元，较前一交易日下跌1.81%，最新总市值为102.26亿元。公司近日发布公告称，华北制药股份有限公司将于2025年11月27日13:00-14:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度经营成果及财务状况。投资者可于2025年11月20日至11月26日16:00前通过上证路演中心网站或公司邮箱提交问题，公司在说明会上将对普遍关注的问题进行回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900039951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0},{"id":"2582864551","title":"每周股票复盘：华北制药（600812）子公司获原料药上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2582864551","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582864551?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:58","pubTimestamp":1762635490,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，华北制药报收于6.17元，较上周的6.0元上涨2.83%。本周，华北制药11月3日盘中最高价报6.2元。华北制药当前最新总市值105.86亿元，在化学制药板块市值排名51/151，在两市A股市值排名1803/5166。公司公告汇总华北制药全资子公司华北制药河北华民药业有限责任公司收到国家药监局签发的头孢托仑匹酯《化学原料药上市申请批准通知书》，批准其化学原料药上市。截至目前，国内共6家企业完成该原料药注册评审。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","BK0028","600812"],"gpt_icon":0},{"id":"2580753150","title":"华北制药（600812）披露下属公司获得《化学原料药上市申请批准通知书》，11月04日股价下跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580753150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580753150?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:45","pubTimestamp":1762267528,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，华北制药报收于6.14元，较前一交易日下跌0.65%，最新总市值为105.35亿元。该股当日开盘6.16元，最高6.18元，最低6.1元，成交额达1.16亿元，换手率为1.1%。公司近日发布公告称，其全资子公司华北制药河北华民药业有限责任公司收到国家药品监督管理局签发的头孢托仑匹酯《化学原料药上市申请批准通知书》，批准其化学原料药上市申请。截至目前，国内共有6家企业完成该原料药注册评审。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400039784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0191","600812"],"gpt_icon":0},{"id":"2580783666","title":"华北制药(600812.SH)：头孢托仑匹酯化学原料药上市申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2580783666","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580783666?lang=zh_cn&edition=full","pubTime":"2025-11-04 16:49","pubTimestamp":1762246149,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华北制药 公告，公司全资子公司华北制药河北华民药业有限责任公司收到国家药品监督管理局核准签发的头孢托仑匹酯《化学原料药上市申请批准通知书》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365029.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","600812","BK0239","BK0191"],"gpt_icon":0},{"id":"2578683302","title":"华北制药（600812）2025年三季报简析：净利润同比增长54.69%，短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578683302","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578683302?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:02","pubTimestamp":1761429771,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华北制药发布2025年三季报。截至本报告期末，公司营业总收入74.85亿元，同比下降1.0%，归母净利润1.59亿元，同比上升54.69%。按单季度数据看，第三季度营业总收入22.1亿元，同比下降5.12%，第三季度归母净利润3500.66万元，同比上升14.85%。本报告期华北制药短期债务压力上升，流动比率达0.67。去年的净利率为2.18%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812"],"gpt_icon":0},{"id":"2577517031","title":"华北制药（600812）披露2025年第三季度报告，10月24日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577517031","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577517031?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:26","pubTimestamp":1761315979,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，华北制药报收于6.08元，较前一交易日下跌0.33%，最新总市值为104.32亿元。该股当日开盘6.12元，最高6.12元，最低6.04元，成交额达1.15亿元，换手率为1.11%。近日，华北制药发布2025年第三季度报告，披露了公司前三季度的经营数据。根据公告，2025年前三季度，公司实现营业收入7,484,828,636.64元，同比下降1.00%；归属于上市公司股东的净利润为158,504,018.75元，同比增长54.69%；扣除非经常性损益后的净利润为143,324,253.00元，同比增长73.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400042899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0},{"id":"2574468482","title":"每周股票复盘：华北制药（600812）董事会延期换届","url":"https://stock-news.laohu8.com/highlight/detail?id=2574468482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574468482?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:27","pubTimestamp":1760210832,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，华北制药报收于6.01元，较上周的5.85元上涨2.74%。本周，华北制药10月10日盘中最高价报6.02元。华北制药当前最新总市值103.12亿元，在化学制药板块市值排名51/150，在两市A股市值排名1830/5158。本周关注点公司公告汇总：华北制药董事会换届延期，现任成员继续履职至换届完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","600812","BK0028"],"gpt_icon":0},{"id":"2574778177","title":"华北制药（600812）披露关于董事会延期换届的提示性公告，10月10日股价上涨1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574778177","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574778177?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:50","pubTimestamp":1760107829,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，华北制药报收于6.01元，较前一交易日上涨1.18%，最新总市值为103.12亿元。该股当日开盘5.95元，最高6.02元，最低5.92元，成交额达1.39亿元，换手率为1.35%。公司近日发布公告称，第十一届董事会、监事会将于2025年10月11日任期届满。公司将积极推进董事会换届及监事会改革等工作进程，并及时履行信息披露义务。董事会延期换届不会影响公司正常运营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600812","BK0028","BK0239"],"gpt_icon":0},{"id":"2569701245","title":"每周股票复盘：华北制药（600812）子公司获注射用亚胺培南西司他丁钠药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2569701245","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569701245?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:44","pubTimestamp":1758397454,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，华北制药报收于5.92元，较上周的6.03元下跌1.82%。本周，华北制药9月18日盘中最高价报6.07元。本周关注点公司公告汇总：全资子公司深圳华药南方制药获注射用亚胺培南西司他丁钠《药品注册证书》，视为通过仿制药一致性评价。公司公告汇总华北制药全资子公司深圳华药南方制药有限公司收到国家药监局核准签发的注射用亚胺培南西司他丁钠《药品注册证书》，批准文号为国药准字H20255370，有效期至2030年9月8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0191","600812"],"gpt_icon":0},{"id":"2567032381","title":"华北制药最新公告：全资子公司获得注射用亚胺培南西司他丁钠药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567032381","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567032381?lang=zh_cn&edition=full","pubTime":"2025-09-16 17:27","pubTimestamp":1758014876,"startTime":"0","endTime":"0","summary":"华北制药(600812.SH)公告称，公司全资子公司深圳华药南方制药有限公司收到国家药品监督管理局核准签发的注射用亚胺培南西司他丁钠（1.0g）《药品注册证书》。该药品适用于由敏感细菌所引起的多种感染，包括腹腔内感染、下呼吸道感染等。截至目前，国内共有10家企业持有该药品的药品注册证书。该药品2024年国内市场销售额达23亿元。南方公司获得该证书，完善了其抗感染领域的产品结构，但制剂产品销售业务仍受行业政策、市场环境等因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600027790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600812","BK0239","BK0191"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770216902839,"stockEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":0.009},{"period":"3month","weight":-0.0912},{"period":"6month","weight":-0.1533},{"period":"1year","weight":0.0116},{"period":"ytd","weight":0.009}],"compareEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":0.0249},{"period":"3month","weight":0.0248},{"period":"6month","weight":0.1176},{"period":"1year","weight":0.2514},{"period":"ytd","weight":0.0249}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华北制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"88011人(较上一季度增加4.79%)","perCapita":"19494股","listingDate":"1994-01-14","address":"河北省石家庄市长安区和平东路388号","registeredCapital":"171573万元","survey":" 华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是抗感染药物、防疫类药物、肾病及免疫调节剂、心脑血管类药物、维生素及健康消费品。公司曾先后获得国家发明奖5项、科技进步奖21项；被授予“中国医药行业功勋企业”和“中国制药大王”“全国医药行业药品质量诚信建设示范企业”等称号。","listedPrice":4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华北制药,600812,华北制药股票,华北制药股票老虎,华北制药股票老虎国际,华北制药行情,华北制药股票行情,华北制药股价,华北制药股市,华北制药股票价格,华北制药股票交易,华北制药股票购买,华北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}